Treatment of Raynaud's phenomenon.
Wollersheim
H
H
van Zwieten
P A
PA
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004599:Electric Stimulation Therapy; D006801:Humans; D007650:Ketanserin / Q000627:therapeutic use; D011928:Raynaud Disease / Q000628:therapy*
D000317:Adrenergic alpha-Antagonists; D002121:Calcium Channel Blockers; D007650:Ketanserin